top of page
Executive Spotlights

Alamar Biosciences Raises $128M in Oversubscribed Series C

Fremont, CA, February 26, 2024 (PRNewswire)  -- Alamar Biosciences, a company specializing in precision proteomics for early disease detection, announced the close of $100 million in Series C financing today, with an additional $28 million expected to be closed within the next 30 days. This additional capital increases Alamar's total funding to nearly $250 million.

Read full article here.

Recent Posts

See All


Life Science Headlines
bottom of page